Board of Directors
Christopher I. Wright, M.D., Ph.D.
Dr. Wright serves as Chief Medical Officer, Head of Translational Research of Ring Therapeutics, a life sciences company founded by Flagship Pioneering. Prior to joining Ring, he served as Chief Medical Officer of AavantiBio, Inc., a gene therapy company which was acquired by Solid Biosciences Inc. Previously, he served as Senior Vice President, Chief Medical Officer of Cyclerion Therapeutics, Inc., where he led global development functions across therapeutic areas, and prior to that, served as Senior Vice President, Chief Development Officer at Ironwood Pharmaceuticals, Inc. Earlier in his career, Dr. Wright held a variety of medicines development and medical affairs roles at Axcella Health Inc. and Vertex Pharmaceuticals Incorporated, most recently as Senior Vice President of Global Medicines Development and Affairs at Vertex. Dr. Wright was an Associate Professor of Neurology at Harvard Medical School and a board-certified practicing neurologist at Brigham and Women’s Hospital for 20 years. He currently serves as a Scientific Advisor for Cyclerion.